Yuqian Yan

ORCID: 0000-0003-1904-5906
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Traditional Chinese Medicine Studies
  • Complementary and Alternative Medicine Studies
  • Digital Mental Health Interventions
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Mobile Health and mHealth Applications
  • Acupuncture Treatment Research Studies
  • Glioma Diagnosis and Treatment
  • Advanced Sensor and Energy Harvesting Materials
  • Nanoplatforms for cancer theranostics
  • Plant-based Medicinal Research
  • Medication Adherence and Compliance
  • Pharmacological Effects of Natural Compounds
  • Medical Research and Treatments
  • Nanoparticle-Based Drug Delivery
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Voice and Speech Disorders
  • Virtual Reality Applications and Impacts
  • Wound Healing and Treatments
  • Meta-analysis and systematic reviews
  • Nausea and vomiting management
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Tuberculosis Research and Epidemiology
  • Medicinal Plants and Bioactive Compounds

University Hospital of Zurich
2020-2025

University of Zurich
2023-2025

Harbin Institute of Technology
2025

Nanjing Medical University
2024

Beijing University of Chinese Medicine
2019

Background: Traditional Chinese medicine (TCM) is widely integrated into cancer care in China. An overview 2011 identified 2384 randomized and non-randomized controlled trials (RCTs, non-RCTs) on TCM for published the literature. This article summarizes updated evidence of RCTs care. Methods: We searched 4 main databases: China National Knowledge Infrastructure, Scientific Journal Database, SinoMed, Wanfang. used were analyzed this bibliometric study. Results: Of 5834 (477 157 patients),...

10.1177/15347354211031650 article EN cc-by-nc Integrative Cancer Therapies 2021-01-01

Understanding the characteristics and expectations of people with multiple sclerosis (pwMS) who utilize complementary therapies can help integrate these into conventional care. To describe pwMS use therapies, their general reasons targeted symptoms, regarding effects therapies. A cross-sectional survey from Swiss Multiple Sclerosis Registry was conducted October 2022 to August 2023. 888 participated (39.3 % participation rate). 48.2 had used in last six months. The most typical were improve...

10.1016/j.msard.2025.106349 article EN cc-by Multiple Sclerosis and Related Disorders 2025-03-01

Background and Aim: The development of accurate noninvasive tests to identify individuals with metabolic dysfunction–associated steatohepatitis (MASH) liver fibrosis is great clinical importance. In this study, we aimed develop 2 diagnostic models on the basis routine laboratory data, using machine learning, patients MASH significant (fibrosis stages 4), respectively. Methods: This analysis included training (n=456) validation (n=105) sets who underwent biopsy testing for disease at...

10.1097/mcg.0000000000002166 article EN Journal of Clinical Gastroenterology 2025-04-25

The objective of this meta-epidemiological study was to develop a rating that captures participants’ motivation at the level in digital health intervention (DHI) randomised controlled trials (RCTs). used investigate whether is associated with effect estimates DHI RCTs for cancer patients. development based on bottom-up approach involving collection information baseline empirical studies from Smartphone-RCCT Database. We specified three indicators rating: indicator 1 team actively selects or...

10.1371/journal.pone.0306772 article EN cc-by PLoS ONE 2024-07-08

Abstract This study aimed to explore the clinical significance of genomics features including tumor mutation burden (TMB) and copy number alteration (CNA) for advanced EGFR mutant lung cancer. We retrospectively identified 1378 patients with cancer next‐generation sequencing tests from three cohorts. Multiple co‐occurring alternations occurred in a large proportion (97%) cancers. Both TMB CNA were predictive biomarkers these patients. A joint analysis found that high showed worse responses...

10.1002/mc.23750 article EN Molecular Carcinogenesis 2024-06-11

Background Mobile health (mHealth) refers to using mobile communication devices such as smartphones support health, care, and public health. mHealth interventions have their own nature characteristics that distinguish them from traditional care interventions, including drug interventions. Thus, randomized controlled trials (RCTs) of present specific methodological challenges. Identifying overcoming those challenges is essential determine whether improve outcomes. Objective We aimed identify...

10.2196/53187 article EN cc-by Journal of Medical Internet Research 2024-12-19

As clinical trials evaluating the efficacy of traditional Chinese medicine (TCM) therapies have increased, several empirical studies shown that quality TCM is generally low in terms risk bias. This qualitative study aimed to investigate factors influencing provide strategic advice on trial improvement.One focus group with auditors (n = 4) and six in-depth semi-structured interviews research organization managers 2), lecturers researchers academic institutions a chief physician oncology...

10.1016/j.ctcp.2019.09.004 article EN cc-by-nc-nd Complementary Therapies in Clinical Practice 2019-09-13

Background and AimsAge-related mosaic chromosomal alterations (mCAs) detected from genotyping of blood-derived DNA are structural somatic variants that indicate clonal hematopoiesis. This study aimed to investigate whether mCAs contribute the risk cirrhosis modify effect a polygenic score (PRS) on prediction.

10.14218/jcth.2023.00575 article EN Journal of Clinical and Translational Hepatology 2024-05-28

Herbal remedies have been widely utilized in treating chronic hepatitis C (CHC) worldwide. Selecting appropriate outcomes to reflect both beneficial and harmful effects is a crucial step designing randomized controlled trials (RCTs). This study evaluated the reported RCTs on herbal for CHC with comparison core recommended by Cochrane Hepato-Biliary Group (CHBG), check consistency of provide recommendation future researches. A systematic literature search was conducted Western Chinese...

10.1016/j.jtcms.2019.03.002 article EN cc-by-nc-nd Journal of Traditional Chinese Medical Sciences 2019-03-23

<sec> <title>BACKGROUND</title> Mobile health (mHealth) refers to using mobile communication devices such as smartphones support health, care, and public health. mHealth interventions have their own nature characteristics that distinguish them from traditional care interventions, including drug interventions. Thus, randomized controlled trials (RCTs) of present specific methodological challenges. Identifying overcoming those challenges is essential determine whether improve outcomes. </sec>...

10.2196/preprints.53187 preprint EN 2023-09-29
Coming Soon ...